India Healthcare: Hospital se seedha Patients tak, Phydigital Model ka 'Bada Game Changer'!

OTHER
Whalesbook Logo
AuthorAarav Shah|Published at:
India Healthcare: Hospital se seedha Patients tak, Phydigital Model ka 'Bada Game Changer'!
Overview

Arre suno, India ka healthcare sector ekdum se badal raha hai! Ab hospitals pe focus karne ke bajaye, patients se continuous connect banane par zor hai. Yeh 'Phydigital' model, matlab physical aur digital dono ka combination, patient support programs ko ek next level business bana raha hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Healthcare ka Naya Trend: Phydigital Fusion!

Dekho, India mein healthcare ka pura scene hi change ho raha hai. Pehle sab hospitals pe atak kar rehta tha, ab patients ke poore journey pe focus hai. Yeh jo naya 'Phydigital' wala funda aaya hai na, matlab physical care aur digital tools ka mast blend, yeh patient support programs ko ek dam zabardast business bana raha hai. Isse chronic diseases ko manage karna easy ho raha hai, log medicines time pe le rahe hain, aur healthcare bade shehron ke bahar bhi pahunch raha hai.

Kyun Ho Raha Hai Yeh Sab? (The Reasons!)

Aajkal diabetes, heart problems, aur saans ki bimariyon (respiratory disorders) jaise chronic diseases badhte ja rahe hain. Inko long-term manage karna bahut zaroori hai. Lekin bahut se patients beech mein hi treatment chhod dete hain, kyunki unhe sahi guidance nahi milti, ya kuch aur reasons hote hain. Jaise Mahesh Makhija sir ne kaha, "Patients ko continuous support chahiye, khaas kar jab long-term management critical ho." Yahi gap ek dum naye business opportunities khol raha hai.

Patient Engagement Se Paisa Kaise? (Monetizing the Model)

Jo pehle sirf patient help karne ke liye hota tha, ab woh ek structured business model ban gaya hai. Pharmaceutical companies, healthcare providers, sab log ab Patient Service Programmes (PSPs) use kar rahe hain. Goal hai ki log treatment na chhoden, jisse unki health bhi acchi rahe aur companies ko bhi long-term benefit mile. Sir ne bataya ki, "Early data dikha raha hai ki yeh programmes bahut hit ho rahe hain. Counselling, reminders, aur lifestyle guidance wale programmes mein six to twelve months tak patients ke participate karne ke chances kaafi badh jaate hain, especially chronic therapies mein." Isse companies ko predictable demand milti hai, brand loyalty badhti hai, aur patients ke baare mein deep insights bhi milte hain.

Shehron Ke Bahar Bhi Healthcare Pahunch Raha Hai!

Yeh growth aur bhi tez ho rahi hai kyunki healthcare ab Tier-2 aur Tier-3 cities mein bhi access ho raha hai. Iska reason hai badhti digital penetration aur smartphones ka use. Makhija sir ne explain kiya, "Programmes ko local needs ke hisaab se design kiya jaa raha hai, jaise local bhasha, culture, aur digital literacy ko dhyan mein rakhte hue. WhatsApp toh ekdum main engagement tool ban gaya hai kyunki sab use karte hain aur bahut easy hai." Yeh localisation aur scalable digital infrastructure companies ko poore desh mein patient networks banane mein help kar raha hai, woh bhi kam kharche mein.

Doctors Ka Time Bhi Bach Raha Hai!

Yeh structured programmes doctors ke liye bhi bahut helpful hain. Unka time hamesha kam rehta hai. Routine follow-ups aur patient education PSPs ko dekar, doctors apna time serious bimariyon ko treat karne mein laga sakte hain. Sir ka kehna hai, "Future mein healthcare sirf patients ko treat karne ke baare mein nahi hoga, balki unke poore journey mein unse connect rehne ke baare mein hoga. Patient programmes is connected-care ecosystem ka backbone banenge."

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.